Progen Pharmaceuticals Limited (PGL)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!


General Information
Company Name: Progen Pharmaceuticals Limited
Stock Code: PGL
Website: www.progen-pharma.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 11
Equiv. Shares (M): 55

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.205 $ 0.205 $ 0.205 $ 0.205 $ 0.205 2,667 0%

Company Overview

Business Description:
Progen Pharmaceuticals Limited (PGL) is a biotechnology company focused on the discovery, development and commercialisation of small molecule pharmaceuticals therapeutics for cancer and other serious diseases. PGL develops of the anti-angiogenesis and anti-metastatic oncology products. PGL focuses on two main anti-cancer product developments, which are PG545 and Muparfostat (PI-88). PGL has operations in Australia and USA.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -1.8 -3.3 -- 0.0 0.0 0.0 --
2013  A -2.1 -7.5 -- 0.0 0.0 0.0 --
2012  A -3.4 -12.6 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Bionomics (BNO) $180 M -- 6.3117 0.3108 55.8442 7.6377 5.8266 0.00 0.00 0.00
CSL (CSL) $40,734 M 0.0899 0.2398 0.0991 30.0347 24.2263 22.0413 1.40 1.76 1.86
Mesoblast (MSB) $1,287 M -- -- -- -- -- -- 0.00 0.00 0.00
Progen Pharmaceuticals (PGL) $9 M -- -- -- -- -- -- 0.00 -- --
Sirtex Medical (SRX) $1,484 M 0.2906 0.5148 0.3552 63.5835 41.9757 30.9743 0.53 0.66 1.07

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
PGL -- -- 1.41 -- 2.05
Market 1.02 13.7 0.95 1.00 2.85
Sector 0.76 16.4 2.55 1.39 7.81

Directors
Name Position Start Date
Mr Indrajit (Jitto) Solomon Arulampalam Chief Executive Officer,Executive Chairman 12 July 2013
Mr Heng H Tang Executive Director,Managing Director 17 July 2009
Dr Hongjen Chang Non-Executive Director 29 November 2013

Management
Name Position
Leslie Tillack Chief Executive Officer - PharmaSynth
Blair Lucas Company Secretary
Fleur Lankesheer Director - Business Development and Legal
Lee Horobin General Manager - Finance

Substantial Shareholders
Holding Name
6,700,000 (12.12%) TBG Inc
4,192,964 (7.58%) Medigen Biotechnology Corp.
5,000,000 (9.04%) Well Hallmark Holding Corp

Calendar of Events
Date Event
12 November 2015 Report (Annual)
28 September 2015 Report (Annual)
25 August 2015 Report (Prelim)
26 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Shares via SMSFs

An educational booklet that outlines how to get the most from your share investments for retirement thorugh your self managed super fund.

More details...

News

Aussie Investors take their foot off the accelerator

By Betty Lam (Sales Trader, CMC Markets) 18/12/2014 | Lead by the Fed-fervour offshore, Australians shares jumped on the Yellen cheer wagon. The material and energy stocks were back in vogue as both sectors gained over 3% in morning trade.

Fed Feeds Frenzy

By Michael McCarthy (chief market strategist, CMC Markets) 18/12/2014 | In spite of a frenzied pre-mortem, a benign statement from the US Federal Reserve‚Äôs Open Market Committee and steadying commodity markets drove investors back into share markets overnight. A calmer, stronger ruble helped offset European growth fears, highlighted in the overnight session by further declines in inflation.

Household brands Woolworths and Telstra Heavy Lifting

By Betty Lam (Sales Trader, CMC Markets) 11/12/2014 | Offshore jitters sent ripples through to Australian stocks. The open saw the local equities take 65 points off the index, catalysed by a mass-exit in energy stocks, yet again.

Steady open as Woodside investors wait on details of possible Wheatstone acquisition

By Ric Spooner (Chief Market Analyst, CMC Markets) 10/12/2014 | Yesterday‚Äôs news on Greek politics and China‚Äôs bond market came at a time when US and European stock markets have extended rallies and pushed valuations higher. This makes those markets vulnerable to downward corrections as profit takers act to avoid missing out.

MYEFO and Lima - December could be nasty.

BR Securities Australia Pty Ltd 2/12/2014 | December 2014 could go down as a nasty moment in Australian finance. MYEFO will reveal a deteriorating budget deficit and the UNFCCC meeting in Lima, Peru will provide the agreement, to be ratified in Paris in 2015, on how much (or little) CO2 is to be allowed into the atmosphere from 2020.

Australian Share Market - Close Up

CMC Markets 11/11/2014 | The Australian share market is in a decision zone - and trading from here may set the direction for the rest of the year.

More...


Sponsored Links